Nevada-based Vanilla Chip LLC, doing business as TruHeight, and its two principals agreed to settle FTC charges alleging the company deceptively advertised the effectiveness of a range of supplements marketed as supporting height growth in children and teenagers — a claim aimed squarely at anxious parents rather than at adult consumers evaluating a product for themselves.DOCUMENTED
- TruHeight marketed supplements with specific claims of supporting height growth in children and teens, a product category with an inherently emotionally invested customer base.
- The FTC alleges the company relied on reviews written by its own employees, or by consumers who received a free product or a discount in exchange for a five-star review — meaning the reviews were compensated even where they were not written by company insiders.
- The company's principals are named individually in the settlement: Eden Stelmach and Justin Rapoport, indicating the FTC viewed the practices as directed at the ownership level.
Two claims, one settlement
This case combines two distinct types of alleged deception the FTC treats separately in its own guidance but which frequently appear together in practice: an unsubstantiated product-effectiveness claim (that a supplement measurably supports height growth in a developing child, a claim requiring genuine clinical substantiation to make responsibly) and a review-integrity violation (that the reviews cited in support of that claim were not actually independent). Each of these two problems undermines a different consumer safeguard — one undermines the underlying factual claim itself, the other undermines the social proof a consumer might reasonably rely on to evaluate that claim before purchase.REVIEWED
The specific vulnerability of the target market makes the alleged conduct particularly notable: a parent concerned about a child's height is arguably a more emotionally motivated buyer than the average consumer of a general wellness supplement, and correspondingly less likely to apply the same level of skepticism to marketing claims and reviews that a more dispassionate purchase decision might invite.
A familiar structure on this site
The pattern is now a familiar one across Watchdog Journal's coverage: a product or earnings claim that would draw meaningful skepticism if evaluated purely on its own scientific or factual merits is propped up by reviews engineered to look independent and organic, when in fact they originate from parties with an undisclosed financial or employment stake in the outcome. Watchdog Journal has documented the same underlying structure in the Publishing.com case, where reviews came from employees and relatives of the company's founders.
Across all three cases, the remedy the FTC has imposed follows an identical logic regardless of the specific industry involved: the underlying product claim must be substantiated on its own merits, and any review or endorsement relied upon to support it must disclose whatever financial or personal relationship exists between the reviewer and the company.
Sources behind this report
Have documents relevant to this story? Reach us through our tips channel.